Barclays analyst Luke Sergott raised the firm’s price target on Certara (CERT) to $13 from $12 and keeps an Equal Weight rating on the shares. The company reported a solid Q4 to end the year with Regulatory rebounding and Chemaxon outperforming management expectations, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERT:
- Certara’s Earnings Call Highlights Growth Amid Challenges
- Certara’s Strategic Growth and AI Integration Drive Buy Rating
- Certara initiated with a Buy at TD Cowen
- Certara’s Growth Potential: A Buy Rating Driven by Strategic Transformation and AI Integration
- Certara, Inc. Reports Strong Q4 2024 Results